Thrombocytosis and Gemcitabine
— · The Internet Journal of Oncology · 2002
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The Internet Journal of Oncology · OpenAlex · article · 2002
Abstract
Gemcitabine (2'-2'-difluorodeoxycytidine, dFdC) is a novel nucleoside analogue of deoxycytidine recently introduced for the treatment of pancreatic cancer and non-small-cell-lung cancer (NSCLC). We studied the occurrence of thrombocytosis when using this drug.
Open the resolved locator · 10.5580/428
Metadata licence: OpenAlex metadata (CC0)